ijms-logo

Journal Browser

Journal Browser

Novel Insight into Pulmonary Vascular Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1651

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA
Interests: pulmonary hypertension; apoptosis; microcirculation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pulmonary vascular diseases include a broad range of disorders that impair blood flow through the lungs. Depending on the disorder, this can result in a variety of effects, which limit gas exchange, enhance pulmonary arterial pressure, and contribute to right heart failure. At present, therapies for most vascular disorders of the lung are limited, and new avenues for treatment need to be identified. The purpose of this Special Issue is to highlight work that investigates/identifies new signal transduction pathways and alternative interpretations and additional effects of established mechanisms contributing to pulmonary vascular disease.

Original research articles and reviews that provide novel insight into pulmonary vascular diseases including, but not limited to, pulmonary hypertension, pulmonary fibrosis, sleep apnea, ischemic lung injury, and vascular effects of lung infection are welcome for submission to this Special Issue. I am excited to receive your valuable contributions to this topic.

Sincerely,

Dr. Charles E. Norton
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pulmonary hypertension
  • pulmonary fibrosis
  • hypoxia
  • smooth muscle cells
  • endothelial dysfunction
  • vasoconstriction
  • vascular remodeling

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 7563 KiB  
Article
HSP70 Is a Critical Regulator of HSP90 Inhibitor’s Effectiveness in Preventing HCl-Induced Chronic Lung Injury and Pulmonary Fibrosis
by Ruben M. L. Colunga Biancatelli, Pavel A. Solopov, Tierney Day, Betsy Gregory, Michael Osei-nkansah, Christiana Dimitropoulou and John D. Catravas
Int. J. Mol. Sci. 2024, 25(3), 1920; https://doi.org/10.3390/ijms25031920 - 05 Feb 2024
Viewed by 715
Abstract
Exposure to hydrochloric acid (HCl) can provoke acute and chronic lung injury. Because of its extensive production for industrial use, frequent accidental exposures occur, making HCl one of the top five chemicals causing inhalation injuries. There are no Food and Drug Administration (FDA)-approved [...] Read more.
Exposure to hydrochloric acid (HCl) can provoke acute and chronic lung injury. Because of its extensive production for industrial use, frequent accidental exposures occur, making HCl one of the top five chemicals causing inhalation injuries. There are no Food and Drug Administration (FDA)-approved treatments for HCl exposure. Heat shock protein 90 (HSP90) inhibitors modulate transforming growth factor-β (TGF-β) signaling and the development of chemical-induced pulmonary fibrosis. However, little is known on the role of Heat Shock Protein 70 (HSP70) during injury and treatment with HSP90 inhibitors. We hypothesized that administration of geranylgeranyl-acetone (GGA), an HSP70 inducer, or gefitinib (GFT), an HSP70 suppressant, alone or in combination with the HSP90 inhibitor, TAS-116, would improve or worsen, respectively, HCl-induced chronic lung injury in vivo and endothelial barrier dysfunction in vitro. GGA, alone, improved HCl-induced human lung microvascular endothelial cells (HLMVEC) barrier dysfunction and, in combination with TAS-116, improved the protective effect of TAS-116. In mice, GGA reduced HCl toxicity and while TAS-116 alone blocked HCl-induced chronic lung injury, co-administration with GGA, resulted in further improvement. Conversely, GFT potentiated HCl-induced barrier dysfunction and impaired the antidotal effects of TAS-116. We conclude that combined treatments with HSP90 inhibitors and HSP70 inducers may represent a novel therapeutic approach to manage HCl-induced chronic lung injury and pulmonary fibrosis. Full article
(This article belongs to the Special Issue Novel Insight into Pulmonary Vascular Disease)
Show Figures

Figure 1

Review

Jump to: Research

21 pages, 3022 KiB  
Review
Role of Sensory Nerves in Pulmonary Fibrosis
by Charles E. Norton
Int. J. Mol. Sci. 2024, 25(6), 3538; https://doi.org/10.3390/ijms25063538 - 21 Mar 2024
Viewed by 657
Abstract
Pulmonary fibrosis results from the deposition and proliferation of extracellular matrix components in the lungs. Despite being an airway disorder, pulmonary fibrosis also has notable effects on the pulmonary vasculature, with the development and severity of pulmonary hypertension tied closely to patient mortality. [...] Read more.
Pulmonary fibrosis results from the deposition and proliferation of extracellular matrix components in the lungs. Despite being an airway disorder, pulmonary fibrosis also has notable effects on the pulmonary vasculature, with the development and severity of pulmonary hypertension tied closely to patient mortality. Furthermore, the anatomical proximity of blood vessels, the alveolar epithelium, lymphatic tissue, and airway spaces highlights the need to identify shared pathogenic mechanisms and pleiotropic signaling across various cell types. Sensory nerves and their transmitters have a variety of effects on the various cell types within the lungs; however, their effects on many cell types and functions during pulmonary fibrosis have not yet been investigated. This review highlights the importance of gaining a new understanding of sensory nerve function in the context of pulmonary fibrosis as a potential tool to limit airway and vascular dysfunction. Full article
(This article belongs to the Special Issue Novel Insight into Pulmonary Vascular Disease)
Show Figures

Figure 1

Back to TopTop